Synlett
The field of C-H functionalization chemistry has experienced rapid growth in the past twenty years, with increasingly powerful applications in organic synthesis. Recognizing the potential of this emerging field to impact drug discovery, a dedicated effort was established in our laboratories more than ten years ago with a goal of facilitating the application of C-H functionalization chemistries to active medicinal chemistry programs. Our approach centered around the strategy of Late-Stage Functionalization (LSF) wherein C−H functionalization chemistry is employed in a systematic and targeted manner to generate high-value analogs from advanced drug leads. To successfully realize this approach, we developed broadly useful LSF chemistry platforms and workflows that increased the success rates of the C- H functionalization chemistries and accelerated access to new derivatives. The LSF strategy, when properly applied, enabled rapid synthesis of molecules designed to address specific medicinal chemistry issues. Several case studies are presented along with descriptions of the group’s platforms and workflows.
For details:
Harnessing the Power of C-H Functionalization Chemistry to Accelerate Drug Discovery
Bing Li a, Sriram Tyagarajan a, Kevin D. Dykstra a, Tim Cernak b, Petr Vachal a, Shane W. Krska a
a. Department of Discovery Chemistry, Merck & Co., Inc., Rahway, NJ 07065, USA
b. Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI 48109 USA
For more information about the used Chemspeed solutions:
FLEX ISYNTH
ISYNTH
Contact us to learn more about this exciting publication:
https://www.chemspeed.com/contact-us/